Tesamorelin Eid Protocol UAE — Post-Feast Visceral Fat Reset & IGF-1 Timing for Dubai Researchers

Published 2026-06-26 · REVIVE Peptides Research Desk · 11 min read
TL;DR. Tesamorelin, a stabilised GHRH(1-44) analog, drops CT-measured visceral adipose tissue by roughly 15-18% at 26 weeks (Stanley 2014, Falutz 2010). The Eid protocol shifts the daily 2 mg subcutaneous dose to roughly 90 minutes after the last late-night meal so the GH/IGF-1 pulse hits the post-feast insulin trough — a fix tailored to UAE late-night eating windows. REVIVE LAB UAE keeps Tesamorelin 5 mg and 10 mg vials in stock in Dubai with same-day dispatch and discreet anonymous packaging across the Emirates.

Every Eid in the UAE follows the same arc: a fortnight of long majlis tables, 11pm karak, and a quiet 2-3 kg crawl on the scale that no amount of morning fasted cardio in Dubai Marina seems to shift. The fat you can pinch is the easy part. The fat you can't — the deep visceral pad wrapped around the liver and mesentery — is the one driving the post-Eid bloating, the elevated fasting glucose, and the dull afternoon fatigue. This is where tesamorelin earns its reputation, and why UAE researchers buy tesamorelin UAE-side rather than wait. REVIVE LAB UAE keeps Tesamorelin 5 mg and 10 mg vials in stock in Dubai with 24h delivery across the Emirates, cash on delivery, and discreet anonymous packaging — the practical baseline for any serious post-Eid peptides UAE reset protocol.

Tesamorelin is not a fat burner in the stimulant sense. It is a 44-amino-acid GHRH analog that restores a near-physiological growth-hormone pulse, lifts IGF-1 modestly, and preferentially mobilises visceral adipose tissue (VAT) — the exact compartment that swells during a feast-heavy fortnight. The Eid protocol on this page is the answer to a single question UAE researchers keep asking: "If I'm eating at 11pm anyway, when do I inject so the peptide actually works?"

Mechanism & Trial Data — Why Tesamorelin Hits Visceral Fat First

Tesamorelin (trans-3-hexenoyl-GHRH(1-44)) is a synthetic, N-terminally stabilised analog of endogenous growth-hormone-releasing hormone. The hexenoyl modification protects against DPP-IV cleavage, giving a half-life long enough for one daily subcutaneous shot to drive a clean nocturnal GH pulse from the pituitary — without the supraphysiological flood you get from exogenous recombinant hGH. That distinction matters. Because the pulse still flows through the patient's own pituitary, the feedback loop stays intact: somatostatin can still brake the system, IGF-1 climbs to roughly 80-100 ng/mL above baseline rather than doubling, and insulin sensitivity is largely preserved.

The pivotal data come from three trials repeatedly cited by UAE researchers:

For a Dubai or Abu Dhabi researcher coming off Eid, the relevant signal is the compartment specificity: tesamorelin shifts deep abdominal and hepatic fat without flattening the subcutaneous layer that holds facial volume and limb shape. That is a profile no GLP-1 and no stimulant can match.

The Eid Protocol — IGF-1 Timing Around Late-Night Meals

The standard tesamorelin label calls for 2 mg subcutaneously once daily, usually morning or bedtime. Neither default fits a UAE feast calendar where the last meal can land at 10:30pm-12:00am for two weeks straight. Inject at 8am and the GH pulse competes with breakfast-driven insulin; inject at midnight on a full stomach and you blunt the pulse entirely, because acute hyperglycaemia suppresses GH release at the pituitary.

The Eid protocol is a simple timing fix: inject roughly 90 minutes after the last solid meal, with at least 60 minutes of no caloric intake before sleep. This lands the GHRH-driven pulse in the post-feast insulin trough, when free fatty acid mobilisation from VAT is already rising and GH-stimulated lipolysis can stack on top.

PhaseDaysDoseTimingGoal
Reset (post-Eid week 1-2)1-142 mg SC daily~90 min post last mealRe-establish nocturnal GH pulse, drop fasting insulin
Build (week 3-12)15-842 mg SC dailySame window, anchor to 10-11pmDrive CT-measurable VAT reduction
Consolidate (week 13-26)85-1822 mg SC dailyShift earlier as eating window narrowsLock in hepatic fat reduction (Stanley 2014)
Off-cycle wash183-2100Re-baseline IGF-1, reassess waist & fasting glucose

Reconstitution uses BAC water 3 mL per 5 mg vial, giving 0.12 mL per 2 mg dose on an insulin syringe — clean, repeatable, no math at 11pm. Site rotation matters more than people think; the abdominal wall absorbs faster than the thigh and gives a sharper morning IGF-1 read on lab follow-up.

What to expect at each milestone (composite of Falutz 2007/2010 and Stanley 2014):

Run the Eid protocol on real, HPLC-tested vials.
Tesamorelin 5 mg and 10 mg vials in stock at REVIVE LAB UAE — same-day Dubai dispatch, cash on delivery, discreet anonymous packaging across the Emirates.
Order REVIVE LAB UAE tesamorelin — the trusted peptides supplier in Dubai

Stacking Notes for the Post-Eid Researcher

Tesamorelin runs cleanly alongside the other in-stock REVIVE peptides UAE researchers commonly use after Eid. BPC-157 at 250-500 mcg/day pairs naturally for gut-lining recovery after a fortnight of heavy meals (Sikiric 2018). GHK-Cu 50 mg or 100 mg subcutaneous twice weekly supports the skin-tightening side of fat loss (Pickart 2018). NAD+ 100 mg vials are popular in the same window for mitochondrial reset (Trammell 2016). The one combination to think carefully about is Retatrutide 5/10 mg — both peptides are weight-relevant, but they hit different axes (GLP-1/GIP/glucagon vs GHRH) and many UAE researchers stage them rather than co-administer.

Where to Buy Tesamorelin in the UAE — 24h Delivery

REVIVE LAB UAE dispatches from a temperature-controlled Dubai facility, so the practical question is not "can I get tesamorelin in the UAE" — it is "how fast does it land at my door". The table below reflects the typical courier windows we hit on in-stock orders placed before 4pm Gulf Standard Time. Cash on delivery is the default; discreet anonymous packaging is standard, never optional.

EmirateTypical delivery windowCash on deliveryDiscreet packaging
DubaiSame day, 4-12 hoursYesYes
Abu DhabiNext day, 18-24 hoursYesYes
SharjahSame day, 6-14 hoursYesYes
AjmanSame day, 8-16 hoursYesYes
Ras Al Khaimah (RAK)Next day, 20-28 hoursYesYes
FujairahNext day, 24-30 hoursYesYes
Umm Al Quwain (UAQ)Next day, 20-28 hoursYesYes
Al AinNext day, 20-28 hoursYesYes

Inside Dubai, the bulk of our same-day tesamorelin runs land in Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills and Arabian Ranches — the residential corridors where most of our researcher base actually lives. If you are running the Eid protocol and need the first vial in your fridge before tonight's injection window, a Dubai order placed before lunch typically arrives in time. Tesamorelin same day delivery, tesamorelin 24h delivery, tesamorelin in stock UAE, tesamorelin cash on delivery and tesamorelin discreet packaging are not premium add-ons — they are the standard REVIVE LAB UAE workflow.

Why REVIVE LAB UAE

REVIVE LAB UAE is a UAE-based research peptides supplier built specifically for the local researcher: cold-chain courier handoff straight from a Dubai-side temperature-monitored store, HPLC-tested vials with batch identity verified before release, and discreet anonymous packaging that never names the contents on the outer label. Tesamorelin 5 mg and 10 mg vials sit on the shelf in real inventory — not drop-shipped, not preorder — which is why same-day Dubai dispatch is realistic rather than aspirational. Every order ships with matching BAC water 3 mL and clear reconstitution notes so the first injection of your Eid protocol is not delayed by a missing diluent. Browse the full REVIVE Peptides catalogue at /products/ to see what else stacks cleanly with tesamorelin for a post-feast reset.

FAQ — Tesamorelin, Eid Protocol & UAE Delivery

Where can I buy tesamorelin in the UAE with 24h delivery?

REVIVE LAB UAE keeps Tesamorelin 5 mg and 10 mg vials in stock in Dubai with same-day dispatch across Dubai, Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, UAQ and Al Ain. Cash on delivery and discreet anonymous packaging are standard, and most Dubai orders land inside a 4-12 hour window — order before 4pm GST and the first vial is in your fridge the same evening.

How does the Eid protocol differ from a normal tesamorelin cycle?

The dose is identical — 2 mg subcutaneous daily — but the timing shifts. Instead of a fixed morning injection, the Eid protocol places the shot roughly 90 minutes after the last solid meal, with at least 60 minutes of no caloric intake before sleep. This aligns the GHRH-driven GH/IGF-1 pulse with the post-feast insulin trough so visceral adipose tissue, not muscle glycogen, becomes the dominant lipolytic substrate overnight.

How long until visceral fat changes show up on imaging?

In Stanley 2014 (JAMA) and Falutz 2010 (JCEM), CT-measured visceral adipose tissue dropped by roughly 15-18% at 26 weeks of 2 mg/day tesamorelin, with measurable trends already at week 12. Waist circumference and trunk-fat percentage usually move first; deep VAT and hepatic fat fraction lag by several weeks but show the largest relative effect by the end of the cycle.

Stop the post-Eid drift. Reset the visceral compartment.
Tesamorelin 5 mg and 10 mg vials, HPLC-tested, same-day Dubai dispatch, discreet anonymous packaging — the trusted peptides UAE workflow.
Buy tesamorelin UAE — order from REVIVE LAB UAE now
Research use only. Not for human consumption. Not medical advice. All references to dosing, protocols and trial endpoints are provided for the purposes of in vitro and preclinical research design. Consult a licensed clinician for any human-use questions.
References
  1. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
  2. Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a GHRH analogue, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials. J Clin Endocrinol Metab. 2010;95(9):4291-4304.
  3. Stanley TL, Feldpausch MN, Oh J, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014;312(4):380-389.
  4. Stanley TL, Fourman LT, Feldpausch MN, et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019;6(12):e821-e830.
  5. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial. N Engl J Med. 2023;389(6):514-526.
  6. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
  7. Sikiric P, Hahm KB, Blagaic AB, et al. Stable gastric pentadecapeptide BPC 157, Robert's stomach cytoprotection/adaptive cytoprotection/organoprotection. Curr Med Chem. 2018;25(15):1972-1989.
  8. Trammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948.